Parataxis Holdings LLC Announces Definitive Agreement with Bridge Biotherapeutics, Inc. to Bring Bitcoin Treasury Company to South Korean Public Markets

Parataxis Holdings LLC, through Parataxis Korea Fund I LLC and affiliates, has entered into a definitive agreement to invest KRW 25 billion in Bridge Biotherapeutics, Inc. for a controlling interest, creating a Bitcoin-native treasury platform on the KOSDAQ. The transaction is subject to shareholder approval and expected to close after a shareholder meeting in August 2025.